Table 1.
NUCB1 expression | ||||
---|---|---|---|---|
Clinicopathologic features | Total | Low (n = 61) | High (n = 39) | P value |
Age (years) | ||||
≤ 65 | 64 | 36 | 28 | 0.2089 |
> 65 | 36 | 25 | 11 | |
Gender | ||||
Male | 56 | 33 | 23 | 0.6830 |
Female | 44 | 28 | 16 | |
Tumor size | ||||
>4 cm | 51 | 38 | 13 | 0.0074** |
≤ 4 cm | 49 | 23 | 26 | |
Tumor location | ||||
Head | 53 | 35 | 18 | 0.3088 |
Body/tail | 47 | 26 | 21 | |
Clinical stage (AJCC) | ||||
III–IV | 31 | 24 | 7 | |
I–II | 69 | 37 | 32 | 0.0279* |
T-Primary tumor | ||||
T3–T4 | 44 | 33 | 11 | |
T1–T2 | 56 | 28 | 28 | 0.0135* |
N-Regional lymph nodes | ||||
N1 | 55 | 41 | 14 | |
N0 | 45 | 20 | 25 | 0.0037** |
M-Distant metastasis | ||||
M0 | 78 | 47 | 31 | 0.8102 |
M1 | 22 | 14 | 8 |
P < 0.05,
P < 0.01.